title: [International approaches to the regulation of cell therapy products].
abstract: This article is a review of the main methods and approaches used in regulation of cell therapy products in the United States of America, Canada, European Union, Australia, Japan and South Korea. Intensive developments ofscientific and technological aspects in stem cell and tissue engineering have led to the wide use of human cells and tissues for the treatment of various diseases and injuries of organs and tissues. Drug regulatory agencies of different countries are working on implementation of a risk-based legal framework with some common features. In many countries there is a multilevel control system that assures quality and safety of used cell products. Competent authorities establish strict requirements both to safety of the products and to the implemented standards of good laboratory, manufacturing, clinical and tissue practices.
authors: N V
authors: NV
authors: Piatigorskaia
authors: M A
authors: MA
authors: Tulina
authors: Zh I
authors: ZhI
authors: Aladysheva
authors: V V
authors: VV
authors: Beregovykh
mesh_terms: D064987:Cell- and Tissue-Based Therapy / Q000592:standards*; D006801:Humans; D007391:International Cooperation; D007880:Legislation, Drug / Q000458:organization & administration*; D023822:Tissue Engineering / Q000331:legislation & jurisprudence*